Ketamine Worth Rs 8 Crore Seized In Mumbai; Two Held

MUMBAI : After raiding a commercial unit on Thursday, the Mumbai police recovered ketamine and strips of a banned drug collectively worth nearly Rs 8.50 crore, an official said.

Two persons were arrested in connection with the seizure from the premises in suburban Andheri.

According to the crime branch official, acting on reliable information, the Anti-Extortion Cell (AEC) of the Mumbai police raided the commercial unit and recovered 15.743 kg of ketamine worth Rs 7.87 crore and 23,410 strips of a banned drug valued at Rs 58,31,500.

The police were trying to get more details about the arrested accused and to whom they were going to supply the drugs, he said. The duo was booked under relevant sections of the NDPS Act and further investigation was underway, the official added.

  • Related Posts

    • Pharma
    • June 17, 2025
    • 82 views
    Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

    Bengaluru-based biopharmaceutical firm Biocon on Monday launched a qualified institutions placement (QIP) to raise Rs 4,500 crore. As part of the offering, the firm will issue up to 139 million…

    • Pharma
    • June 17, 2025
    • 90 views
    Zydus Healthcare appoints Swati Dalal MD

    Zydus Lifesciences Ltd on Monday announced the appointment of Swati Dalal as an additional director and Managing Director of its wholly-owned arm Zydus Healthcare Ltd. The board of Zydus Healthcare…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

    Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

    Zydus Healthcare appoints Swati Dalal MD

    Zydus Healthcare appoints Swati Dalal MD

    Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda

    Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda

    Natco API plant gets one observation from FDA

    Natco API plant gets one observation from FDA